CS logo
small CS logo
Goshen Health

Goshen, Indiana, United States
General hospital in Goshen, Indiana
200 High Park Ave, Goshen, IN 46526

About Goshen Health


"Count on Goshen Health to provide your family with exceptional healthcare services for every stage of life. We have earned local, state and national recognition for our dedication to improving the health of our community. Goshen Hospital ranks as one of the best in Indiana. Its Magnet designation means our nurses go beyond the standard of care to take care of you. Our dedicated doctors and specialists provide compassionate care with medical excellence from 38 locations in four counties. That means you can find family doctors and pediatricians, cancer care specialists and heart treatment, orthopedic medicine, women’s health services and more close to home."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Aadi Bioscience, Inc.
1
Arcus Biosciences, Inc.
1
Bryan Schneider, MD
1
Chemo Mouthpiece
1
Costantine Albany
1
Curegenix Inc.
1
Eli Lilly and Company
1
Hoffmann-La Roche
1
Hoosier Cancer Research Network
1
Mirati Therapeutics Inc.
1
Nasser Hanna, M.D.
1
Total Rows: 13

Clinical Trials at Goshen Health


During the past decade, Goshen Health conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11220011001122220000111111111111Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
2012-01-01
2018-12-31
Completed
36
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
2012-12-01
2017-06-21
Terminated
72
Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
2013-04-01
2017-10-01
Completed
200
Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
2014-04-03
2024-02-01
Active, not recruiting
196
Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC
2015-03-01
2022-09-01
Active, not recruiting
93
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
2016-02-01
2023-03-01
Recruiting
72
Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer
2018-03-19
2020-03-05
Terminated
101

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Goshen Health" #1 sponsor was "Aadi Bioscience, Inc." with 1 trials, followed by "Arcus Biosciences, Inc." with 1 trials sponsored, "Bryan Schneider, MD" with 1 trials sponsored, "Chemo Mouthpiece" with 1 trials sponsored and "Costantine Albany" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Goshen Health" #1 collaborator was "Hoosier Cancer Research Network" with 4 trials as a collaborator, "Achieve Life Sciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAadi Bioscience, Inc.: 1Aadi Bioscience, Inc.: 1Arcus Biosciences, Inc.: 1Arcus Biosciences, Inc.: 1Bryan Schneider, MD: 1Bryan Schneider, MD: 1Chemo Mouthpiece: 1Chemo Mouthpiece: 1Costantine Albany: 1Costantine Albany: 1Curegenix Inc.: 1Curegenix Inc.: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1Hoosier CancerResearch Network: 1Hoosier CancerResearch Network: 1Mirati Therapeutics Inc.: 1Mirati Therapeutics Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsHoosier CancerResearch Network: 4Hoosier CancerResearch Network: 4Achieve Life Sciences: 2Achieve Life Sciences: 2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2ARMO BioSciences: 1ARMO BioSciences: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Gilead Sciences: 1Gilead Sciences: 1GlaxoSmithKline: 1GlaxoSmithKline: 1Strategic ResearchInitiative Grant throughIUSCC: 1Strategic ResearchInitiative Grant throughIUSCC: 1Vera BradleyFoundation for BreastCancer: 1Vera BradleyFoundation for BreastCancer: 1Walther Cancer Institute: 1Walther Cancer Institute: 1

Clinical Trials Conditions at Goshen Health


According to Clinical.Site data, the most researched conditions in "Goshen Health" are "Advanced Solid Tumor" (3 trials), "Esophageal Cancer" (2 trials), "Melanoma" (2 trials), "Metastatic Cancer" (2 trials) and "Solid Tumor" (2 trials). Many other conditions were trialed in "Goshen Health" in a lesser frequency.

Clinical Trials Intervention Types at Goshen Health


Most popular intervention types in "Goshen Health" are "Drug" (12 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (3 trials), "Cisplatin" (2 trials), "OGX-427" (2 trials), "AB308" (1 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Goshen Health


The vast majority of trials in "Goshen Health" are 12 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Goshen Health


Currently, there are NaN active trials in "Goshen Health". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Goshen Health, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Goshen Health, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 8Phase 2: 8Phase 1: 3Phase 1: 3Not Applicable: 1Not Applicable: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 5Recruiting: 5Active, not recruiting: 3Active, not recruiting: 3Completed: 3Completed: 3Terminated: 2Terminated: 2

Departments of Goshen Health


Goshen Health has several departments that took part in Clinical trials: "Goshen Center for Cancer Care" - 141 trials
Departments List
Name
City
Trials
Total Rows: 1